跳至主要内容
临床试验/LBCTR2023105464
LBCTR2023105464尚未招募Unknown

Gastroesophageal Reflux Disease and Probiotics - GERD and Probiotics

ebanese American University0 个研究点目标入组 400 人开始时间: 2023年11月21日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 至 50(—)
性别
All

入选标准

  • Patients with mild to moderate GERD symptoms (diagnosed on basis of clinical presentation)
  • Patients with GERD regardless of prior treatment for GERD but not currently on PPIs over at least 4 weeks

排除标准

  • Patients less than 18 years or above the age of 50
  • Prior bariatric surgery
  • Epigastric mass
  • Prior endoscopy showing severe erosive esophagitis LA-C or LA-D
  • Alarm symptoms: weight loss, anemia, dysphagia or odynophagia, family history of malignancy, melena, hematemesis, nausea and vomiting
  • Pregnant women
  • Malignancy, IBD, immunosuppressive therapy
  • Advanced cardiac disease
  • Chronic uninterrupted use of PPI
  • Use of probiotics within the last 6 months

研究者

发起方
ebanese American University

相似试验